Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring

BACKGROUND: Inhibitors of sodium-glucose co-transporter 2 (SGLT2) have immediate glucose-lowering effects by promoting urinary glucose excretion, without altering insulin level. Only a few studies have evaluated blood glucose dynamics in the early period after administration. The present retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Torimoto, Keiichi, Okada, Yosuke, Koikawa, Kenji, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544992/
https://www.ncbi.nlm.nih.gov/pubmed/28785316
http://dx.doi.org/10.1186/s13098-017-0258-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544992/
https://www.ncbi.nlm.nih.gov/pubmed/28785316
http://dx.doi.org/10.1186/s13098-017-0258-5

Ejemplares similares